Lee-Ming Chuang Selected Research

Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)

1/2024	Residual risk of cardiovascular complications in statin-using patients with type 2 diabetes: the Taiwan Diabetes Registry Study.
1/2016	Serum Vascular Adhesion Protein-1 Predicts End-Stage Renal Disease in Patients with Type 2 Diabetes.
1/2015	Severe hepatic injury associated with different statins in patients with chronic liver disease: a nationwide population-based cohort study.
3/2014	Association between plasma triglycerides and high-density lipoprotein cholesterol and microvascular kidney disease and retinopathy in type 2 diabetes mellitus: a global case-control study in 13 countries.
3/2011	Serum vascular adhesion protein-1 predicts 10-year cardiovascular and cancer mortality in individuals with type 2 diabetes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Lee-Ming Chuang Research Topics

Disease

58	Type 2 Diabetes Mellitus (MODY) 01/2024 - 11/2002
42	Insulin Resistance 10/2023 - 01/2002
27	Hypertension (High Blood Pressure) 02/2023 - 11/2002
21	Obesity 08/2023 - 11/2002
16	Metabolic Syndrome (Dysmetabolic Syndrome X) 06/2019 - 02/2002
12	Cardiovascular Diseases (Cardiovascular Disease) 01/2024 - 03/2011
11	Inflammation (Inflammations) 10/2023 - 01/2010
9	Neoplasms (Cancer) 01/2021 - 01/2011
7	Coronary Artery Disease (Coronary Atherosclerosis) 10/2022 - 02/2002
7	Body Weight (Weight, Body) 01/2021 - 02/2004
6	Weight Loss (Weight Reduction) 01/2024 - 01/2009
6	Diabetes Mellitus 01/2016 - 11/2002
5	Hyperglycemia 01/2020 - 05/2009
5	Atherosclerosis 01/2018 - 05/2009
4	Heart Failure 01/2024 - 03/2015
4	Overweight 01/2021 - 11/2002
4	Infections 10/2019 - 08/2005
4	Hypoglycemia (Reactive Hypoglycemia) 01/2018 - 03/2013
3	Chronic Renal Insufficiency 01/2024 - 01/2021
3	Pancreatic Neoplasms (Pancreatic Cancer) 01/2016 - 01/2011
3	Proteinuria 01/2016 - 03/2011
3	Malnutrition (Nutritional Deficiencies) 07/2015 - 06/2013
3	Morbid Obesity 09/2011 - 11/2002
2	Fatty Liver 10/2023 - 01/2023
2	Fibrosis (Cirrhosis) 02/2023 - 03/2021
2	Dyslipidemias (Dyslipidemia) 10/2022 - 02/2006
2	Hypercholesterolemia 06/2019 - 02/2011
2	Abdominal Obesity 06/2019 - 02/2014
2	Hypertriglyceridemia 06/2019 - 02/2016
2	Hyperinsulinism (Hyperinsulinemia) 06/2019 - 11/2002
2	Atherosclerotic Plaque (Atheroma) 01/2018 - 01/2018
2	Pathologic Constriction (Stenosis) 01/2018 - 10/2015
2	Mitochondrial Diseases (Mitochondrial Disease) 01/2018 - 03/2016
2	Gestational Diabetes (Gestational Diabetes Mellitus) 01/2017 - 12/2014
2	Birth Weight (Birth Weights) 01/2016 - 06/2010
2	Diabetes Complications 01/2016 - 06/2015
2	Diabetic Nephropathies (Diabetic Nephropathy) 06/2015 - 03/2014
2	Colorectal Neoplasms (Colorectal Cancer) 08/2014 - 05/2012
2	Stomach Neoplasms (Stomach Cancer) 12/2013 - 10/2012
2	Hyperlipidemias (Hyperlipidemia) 06/2013 - 01/2010
2	Nausea 03/2013 - 01/2009

Drug/Important Bio-Agent (IBA)

46	Glucose (Dextrose)FDA LinkGeneric 01/2024 - 01/2002
29	Insulin (Novolin)FDA Link 01/2024 - 01/2002
20	AdiponectinIBA 11/2016 - 02/2002
14	Triglycerides (Triacylglycerol)IBA 01/2024 - 07/2002
13	CholesterolIBA 01/2024 - 09/2004
11	Aluminum Oxide (Sapphire)IBA 02/2023 - 01/2008
10	Hemoglobins (Hemoglobin)IBA 04/2022 - 06/2009
8	Biomarkers (Surrogate Marker)IBA 11/2023 - 02/2006
8	LipidsIBA 10/2023 - 09/2004
7	LDL CholesterolIBA 01/2024 - 09/2004
6	AldehydesIBA 01/2023 - 03/2011
6	Metformin (Glucophage)FDA LinkGeneric 06/2021 - 01/2009
5	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2024 - 03/2011
5	Hypoglycemic Agents (Hypoglycemics)IBA 01/2023 - 07/2012
5	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 01/2018 - 03/2011
4	C-Reactive ProteinIBA 10/2023 - 08/2007
4	Proteins (Proteins, Gene)FDA Link 03/2021 - 01/2015
4	human AOC3 proteinIBA 01/2018 - 05/2009
4	HDL CholesterolIBA 03/2014 - 07/2002
4	Messenger RNA (mRNA)IBA 12/2013 - 03/2008
3	Alanine Transaminase (SGPT)IBA 01/2024 - 11/2015
3	CalciumIBA 02/2023 - 06/2015
3	AlbuminsIBA 01/2021 - 12/2009
3	Rosiglitazone (Avandia)FDA Link 12/2018 - 05/2012
3	Dipeptidyl-Peptidase IV InhibitorsIBA 01/2018 - 02/2016
3	Amine Oxidase (Copper-Containing)IBA 01/2018 - 09/2013
3	Sitagliptin Phosphate (Januvia)FDA Link 01/2018 - 02/2016
3	Acarbose FDA LinkGeneric 02/2017 - 03/2015
3	ProstaglandinsIBA 01/2016 - 07/2012
3	AmmoniaIBA 01/2016 - 03/2011
3	AminesIBA 01/2016 - 03/2011
3	Uric Acid (Urate)IBA 01/2010 - 11/2002
2	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2024 - 03/2016
2	alpha-2-HS-GlycoproteinIBA 11/2023 - 10/2023
2	15-ketoprostaglandin E2IBA 10/2023 - 01/2016
2	CreatinineIBA 10/2023 - 01/2021
2	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 01/2021 - 11/2016
2	AcidsIBA 06/2019 - 01/2014
2	2,4-thiazolidinedione (thiazolidinedione)IBA 12/2018 - 12/2011
2	Pioglitazone (Actos)FDA Link 12/2018 - 05/2012
2	ThiazolidinedionesIBA 12/2018 - 05/2012
2	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 12/2018 - 10/2012
2	ApolipoproteinsIBA 01/2018 - 01/2018
2	PXS-4728AIBA 01/2018 - 01/2018
2	Mitochondrial DNA (mtDNA)IBA 01/2018 - 05/2012
2	Oxidoreductases (Dehydrogenase)IBA 01/2016 - 10/2012
2	IronIBA 11/2015 - 06/2015
2	Insulin Glargine (Lantus)FDA Link 04/2015 - 01/2011
2	AdipokinesIBA 01/2014 - 01/2010
2	C-PeptideIBA 06/2013 - 01/2013
2	Exenatide (Byetta)FDA Link 03/2013 - 01/2009

Therapy/Procedure

16	Therapeutics 01/2024 - 08/2005
12	Gastric Bypass (Roux-en-Y Gastric Bypass) 01/2024 - 02/2011
12	Glycemic Control 01/2024 - 06/2010
3	Gastrectomy 01/2024 - 02/2011
2	Precision Medicine 08/2023 - 01/2022
2	Surgical Amputation (Amputations) 01/2021 - 11/2012
2	Bariatric Surgery 01/2021 - 01/2013
2	Cesarean Section (Caesarean Section) 01/2016 - 12/2014